Health Condition 1: null- KALLADAIPPU(KIDNEY STONE)
Conditions
Interventions
Intervention1: NANDUKKAL PARPAM WITH SIRUPEELAI KUDINEER: The drug Nandukkal parpam to be used in this study is being of marine products which will have a potent diuretic and lithotriptic effect used
Sponsors
AYOTHIDOSS PANDITHAR HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: • Age between 20 and 60 years • Both male and female patients • Classical pain is described as pain from loin to groin, accompanied by nausea, vomiting and gaseous distension. • Pain and or burning while passing urine. • Patient with renal calculus detected on X-ray KUB or USG abdomen • History of Recurrence of renal stone • Stone size 5mm & > 5mm to • Urine routine which will show Crystals in urine. • Patients are willing and able to give informed consent for participation in the study. • Ability to understand study procedures and to comply with them for the entire length of the study.
Exclusion criteria
Exclusion criteria: • Stone size > 10 mm • Obstruction requiring immediate surgery (Marked hydronephrosis) • Pregnancy and Lactation • women with childbearing potential without adequate contraception • Use of disallowed concomitant medications (NSAID) • Patient taking any other lithotriptic agent • History of Diabetes/ Hypertension • History of hepatic/ renal/ cardiac disease • History of taking treatment for any other ailments. • History of drug/alcohol abuse o Experiencing habitual alcohol-related legal problems. o Repeated drinking despite ongoing alcohol-related relationship problems. o Failure to attend to important responsibilities at work, school or college, or home. • Inability or unwillingness of individual or legal guardian/representative to give written informed consent. • Treatment with another investigational drug or other intervention (within a period of 30 days) • Participated in any research study within the past six months. • Donated blood within the past six months. • Any psychiatric condition that could prevent patient from signing the informed consent or could put the patient at an unacceptable risk in case of participating in the trial • Medical condition, laboratory finding, or physical exam finding (e.g., vital signs outside of specific range) that precludes participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| STONE EXPULSION,REDUCTION IN STONE SIZETimepoint: AFTER 60 DAYS OF TREATMENT | — |
Secondary
| Measure | Time frame |
|---|---|
| RENAL FUNCTION -UREA,CREATININE,URIC ACID LEVELTimepoint: PRE STUDY SCREENING AND AFTER 60 DAYS OF TREATMENT | — |
Countries
India
Contacts
Public ContactDR THOMAS M WALTER
NATIONAL INSTITUTE OF SIDDHA
Outcome results
None listed